SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-020615
Filing Date
2021-08-19
Accepted
2021-08-18 19:22:09
Documents
15
Period of Report
2021-08-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40369
2 ex99-1.htm EX-99.1 23129
3 ex99-1_001.jpg GRAPHIC 3869
  Complete submission text file 0001493152-21-020615.txt   293316

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptix-20210817.xsd EX-101.SCH 3798
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptix-20210817_def.xml EX-101.DEF 27774
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptix-20210817_lab.xml EX-101.LAB 36873
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptix-20210817_pre.xml EX-101.PRE 26392
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5422
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 211187963
SIC: 7389 Services-Business Services, NEC